Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Cs-758
2. R-120758
1. Embeconazole [inn]
2. Cs-758
3. 329744-44-7
4. R-120758
5. 02b953tlai
6. 4-[(1e,3e)-4-[5-[(2r,3r)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1,2,4-triazol-1-yl)butan-2-yl]sulfanyl-1,3-dioxan-2-yl]buta-1,3-dienyl]-3-fluorobenzonitrile
7. Unii-02b953tlai
8. 4-((1e,3e)-4-(trans-5-(((1r,2r)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1h-1,2,4-triazol-1-yl)propyl)thio)-1,3-dioxan-2-yl)-1,3-butadienyl)-3-fluorobenzonitrile
9. 4-[(1e,3e)-4-[trans-5-[[(1r,2r)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1h-1,2,4-triazol-1-yl)propyl]thio]-1,3-dioxan-2-yl]-1,3-butadienyl]-3-fluorobenzonitrile
10. Chembl475786
11. Schembl2927801
12. Schembl2927804
13. Schembl2927807
14. Schembl4681178
15. Cs-758, R-120758
16. Q27231514
17. (2r,3r)-1-(1h-1,2,4-triazole-1-yl)-2-(2,4-difluorophenyl)-3-[2alpha-[(1e,3e)-4-(2-fluoro-4-cyanophenyl)-1,3-butadienyl]-1,3-dioxane-5beta-ylthio]-2-butanol
18. (2r,3r)-3-[[trans-2-[(1e,3e)-4-(4-cyano-2-fluorophenyl)-1,3-butadien-1-yl]-1,3-dioxan-5-yl]thio]-2-(2,4-difluorophenyl)-1-(1-h-1,2,4-triazol-1-yl)-2-butanol
19. (2r,3r)-3-[[trans-2-[(1e,3e)-4-(4-cyano-2-fluorophenyl)-1,3-butadien-1-yl]-1,3-dioxan-5-yl]thio]-2-(2,4-difluorophenyl)-1-(1h-1,2,4-triazol-1-yl)-2-butanol
20. 4-((1e,3e)-4-(trans-5-(((2r,3r)-3-(2,4-difluorophenyl)-3-hydroxy-4-(1h-1,2,4-triazol-1-yl)butan-2-yl)sulfanyl)-1,3-dioxan-2-yl)buta-1,3-dien-1-yl)-3-fluorobenzonitrile
21. 4-[(1e,3e)-4-[5-[(1r,2r)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1,2,4-triazol-1-yl)propyl]sulfanyl-1,3-dioxan-2-yl]buta-1,3-dienyl]-3-fluoro-benzonitrile
22. Benzonitrile, 4-[(1e,3e)-4-[5-[[(1r,2r)-2-(2,4-difluorophenyl)-2-hydroxy-1-methyl-3-(1h-1,2,4-triazol-1-yl)propyl]thio]-1,3-dioxan-2-yl]-1,3-butadienyl]-3-fluoro-
| Molecular Weight | 542.6 g/mol |
|---|---|
| Molecular Formula | C27H25F3N4O3S |
| XLogP3 | 4.2 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 9 |
| Exact Mass | 542.15994633 g/mol |
| Monoisotopic Mass | 542.15994633 g/mol |
| Topological Polar Surface Area | 119 Ų |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 868 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 2 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
31
PharmaCompass offers a list of Embeconazole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Embeconazole manufacturer or Embeconazole supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Embeconazole manufacturer or Embeconazole supplier.
PharmaCompass also assists you with knowing the Embeconazole API Price utilized in the formulation of products. Embeconazole API Price is not always fixed or binding as the Embeconazole Price is obtained through a variety of data sources. The Embeconazole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A 02B953TLAI manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of 02B953TLAI, including repackagers and relabelers. The FDA regulates 02B953TLAI manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. 02B953TLAI API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A 02B953TLAI supplier is an individual or a company that provides 02B953TLAI active pharmaceutical ingredient (API) or 02B953TLAI finished formulations upon request. The 02B953TLAI suppliers may include 02B953TLAI API manufacturers, exporters, distributors and traders.
02B953TLAI Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of 02B953TLAI GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right 02B953TLAI GMP manufacturer or 02B953TLAI GMP API supplier for your needs.
A 02B953TLAI CoA (Certificate of Analysis) is a formal document that attests to 02B953TLAI's compliance with 02B953TLAI specifications and serves as a tool for batch-level quality control.
02B953TLAI CoA mostly includes findings from lab analyses of a specific batch. For each 02B953TLAI CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
02B953TLAI may be tested according to a variety of international standards, such as European Pharmacopoeia (02B953TLAI EP), 02B953TLAI JP (Japanese Pharmacopeia) and the US Pharmacopoeia (02B953TLAI USP).
